HERPES ZOSTER - SHINGLES , CHICKENPOX - VARICELLA

nassruto 1,093 views 21 slides Jul 05, 2016
Slide 1
Slide 1 of 21
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21

About This Presentation

PEngenalan asas mengenai HERPES ZOSTER - SHINGLES , CHICKENPOX - VARICELLA


Slide Content

HERPES ZOSTER -
SHINGLES
CHICKENPOX - VARICELLA
Disediakan
Oleh : Nassruto

DEFINISI
HERPES ZOSTER -
SHINGLES
•Infeksi kulit melibatkan & saraf dengan ledakan
inflamatori di dalam kulit bermula dari T3 – L3

Agen Penyebab
•Human (alpha) herpesvirus 3 (Virus Varicella Zoster –
V-Z Virus), a member of the Herpesvirus group
•Reactivation infection with the virus that causes
CHICKENPOX
•Attack to skin area supplied by sensory nerves

Insiden
•Semua golongan seluruh dunia
•Pesakit leukaemia, Hodgkin & limpoma
•Pesakit menerima rawatan kanser, kosteroid
•Belaku banyak pada orang dewasa - tua
•10% pada kanak-kanak
•Pesakit HIV berisiko tinggi mendapat zoster

Reservoir
•Man

Mode of transmission
•Direct contact
•Droplet / airborne
•Respiratory tract
•Vesicle fluid

Incubation period
•2-3 weeks
•Commonly 13- 17 days.

Period of
communicability
•1 week
•10-21 days – susceptible persons

Susceptibility and
resistance
•Universal among those not previously infected
•More severe in adults than of children
•Second attacks are rare
•Leukemia patient – suffer more severe, prolong or
fatal chickenpox.

Susceptibility and
resistance
•Cancer patients
•Steroid therapy
•Immuno-deficient patients
•Immunisuppressive therapy

Menifestasi Klinikal
•Kesakitan tulang belakang
•Bintik merah pada dada, leher, muka dan selaput
mukosa
•Sakit yang kuat atau rasa kebas

Komplikasi
•Parut
•Neuralgia
•Motor palsi
•Keratitis

Penyelidikan
•Calitan lesi
•Serologi

Rawatan
•Simptomatik
•Antiviral
•Steroid
•Vitamin E

Method of control
•Preventive measures
•control of patients, contact and the immediate
environment

Preventive measures
•Health education
•personal hygiene
•Avoid contaminating skin
•with infectious material
•Health personnel
•wear glove

Preventive measures
•Protect high risk individu
•Neonates
•Immuno-deficient patients

Control of patients,
contact and the
immediate environment
•Report - notification
•Isolation from;
•neonatal
•severe primary lesion
•drainage/ secretion
•newborn baby
•School children at least 5 days
•immunosuppressed patients

Control of patients,
contact and the
immediate environment
•Concurrent disinfection;
•Discharges from nose, throat, lesions
•Quarantine ; none
•Immunization of contacts:
•VZIG given within 96 hours
•Investigation of contacts and source of infection; of no
practical importance

Control of patients,
contact and the
immediate environment
•Specific treatment:
•zovirax
•Epidemic measures: none
•Disaster implications: outbreaks
•International measure: none

THANK YOU
Tags